Haematologica. 2019 Oct 24. pii: haematol.2019.231407. doi: 10.3324/haematol.2019.231407. [Epub ahead of print]

Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort.

1: Department of Paediatrics and Child Health, Makerere University, Kampala Uganda.
2: Makerere University, Kampala Uganda and Université de Montréal, Canada.
3: Department of Pediatrics, Cincinnati Children Hospital Medical Center, Cincinnati, USA.
4: Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, USA.
5: St. Luke University Health Network, Bethlehem, USA.
6: Ryan White Center for Infectious Diseases and Global Health, Indianapolis, USA.
7: Global Health Center, Cincinnati Children Hospital Medical Center, Cincinnati, USA russell.ware@cchmc.org.

*_.

Hemoglobinopathies; Hydroxyurea; Sickle Cell Anemia; Stroke; Transcranial Doppler

Free full text

PubMed